Wednesday, 19 June 2019

J&J sells ASP biz to Fortive Corporation

03 April 2019 | News

Divestiture for an aggregate value of approximately $2.8 billion

Johnson & Johnson announced that it has completed the divestiture of its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc., to Fortive Corporation for an aggregate value of approximately $2.8 billion, consisting of $2.7 billion of cash proceeds from Fortive Corporation and $0.1 billion of retained net receivables. ASP is a global leader in innovative infection prevention solutions with 2018 net revenue of approximately $800 million.

ASP supports healthcare facilities in the fight to protect patients against hospital-acquired infections, which are a leading cause of morbidity and mortality. ASP solutions include capital, consumables and software for use in Low-Temperature Terminal Sterilization and High-Level Disinfection of reusable surgical instruments.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account